Literature DB >> 28315493

An osteogenesis/angiogenesis-stimulation artificial ligament for anterior cruciate ligament reconstruction.

Hong Li1, Jinyan Li2, Jia Jiang1, Fang Lv3, Jiang Chang2, Shiyi Chen4, Chengtie Wu5.   

Abstract

To solve the poor healing of polyethylene terephthalate (PET) artificial ligament in bone tunnel, copper-containing bioactive glass (Cu-BG) nanocoatings on PET artificial ligaments were successfully prepared by pulsed laser deposition (PLD). It was hypothesized that Cu-BG coated PET (Cu-BG/PET) grafts could enhance the in vitro osteogenic and angiogenic differentiation of rat bone marrow mesenchymal stem cells (rBMSCs) and in vivo graft-bone healing after anterior cruciate ligament (ACL) reconstruction in a goat model. Scanning electron microscope and EDS mapping analysis revealed that the prepared nanocoatings had uniform element distribution (Cu, Ca, Si and P) and nanostructure. The surface hydrophilicity of PET grafts was significantly improved after depositing Cu-BG nanocoatings. The in vitro study displayed that the Cu-BG/PET grafts supported the attachment and proliferation of rBMSCs, and significantly promoted the expression of HIF-1α gene, which up-regulated the osteogenesis-related genes (S100A10, BMP2, OCN) and angiogenesis-related genes (VEGF) in comparison with PET or BG coated PET (BG/PET) grafts which do not contain Cu element. Meanwhile, Cu-BG/PET grafts promoted the bone regeneration at the graft-host bone interface and decreased graft-bone interface width, thus enhancing the bonding strength as well as angiogenesis (as indicated by CD31 expression) in the goat model as compared with BG/PET and pure PET grafts. The study demonstrates that the Cu-containing biomaterials significantly promote osteogenesis and angiogenesis in the repair of bone defects of large animals and thus offering a promising method for ACL reconstruction by using Cu-containing nanobioglass modified PET grafts. STATEMENT OF SIGNIFICANCE: It remains a significant challenge to develop an artificial graft with distinct osteogenetic/angiogenetic activity to enhance graft-bone healing for ligament reconstruction. To solve these problems, copper-containing bioactive glass (Cu-BG) nanocoatings on PET artificial ligaments were successfully prepared by pulsed laser deposition (PLD). It was found that the prepared Cu-BG/PET grafts significantly stimulated the proliferation and osteogenic/angiogenic differentiation of bone marrow stromal cells (BMSCs) through activating HIF-1α/S100A10/Ca2+ signal pathway. The most important is that the in vivo bone-forming ability of Cu-containing biomaterials was, for the first time, elucidated in a large animal model, revealing the enhanced capacity of osteogenesis and angiogenesis with incorporation of bioactive Cu element. It is suggested that the copper-containing biomaterials significantly promote osteogenesis and angiogenesis in large animal defects and thus offering a promising method for ACL reconstruction by using Cu-containing nanobioglass modification of PET grafts, paving the way to apply Cu-containing biomaterials for tissue engineering and regenerative medicine.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anterior cruciate ligament; Artificial ligament; Bioactive glass; Copper; Osteogenesis

Mesh:

Substances:

Year:  2017        PMID: 28315493     DOI: 10.1016/j.actbio.2017.03.014

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  9 in total

Review 1.  Current strategies for enhancement of the bioactivity of artificial ligaments: A mini-review.

Authors:  Shenglin Li; Shuhan Wang; Wenliang Liu; Chao Zhang; Jian Song
Journal:  J Orthop Translat       Date:  2022-10-12       Impact factor: 4.889

Review 2.  Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Authors:  Kalim Deshmukh; Tomáš Kovářík; Tomáš Křenek; Denitsa Docheva; Theresia Stich; Josef Pola
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 4.036

Review 3.  Bone biomaterials and interactions with stem cells.

Authors:  Chengde Gao; Shuping Peng; Pei Feng; Cijun Shuai
Journal:  Bone Res       Date:  2017-12-21       Impact factor: 13.567

4.  Exosomes derived from magnetically actuated bone mesenchymal stem cells promote tendon-bone healing through the miR-21-5p/SMAD7 pathway.

Authors:  Xiang-Dong Wu; Lin Kang; Jingjing Tian; Yuanhao Wu; Yue Huang; Jieying Liu; Hai Wang; Guixing Qiu; Zhihong Wu
Journal:  Mater Today Bio       Date:  2022-06-11

5.  [Three-dimensional printed Ti6Al4V-4Cu alloy promotes osteogenic gene expression through bone immune regulation].

Authors:  Chenke Zhang; Yanjin Lu; Yupeng Guo; Wan Chen; Hong Tang; Huaisheng Li; Kanglai Tang; Qingyi He
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-09-15

6.  Acceleration of ligamentization and osseointegration processes after anterior cruciate ligament reconstruction with autologous tissue-engineered polyethylene terephthalate graft.

Authors:  Jiangyu Cai; Junjie Xu; Yuhao Kang; Yufeng Li; Liren Wang; Xiaoyu Yan; Jia Jiang; Jinzhong Zhao
Journal:  Ann Transl Med       Date:  2021-05

7.  Multifunctional Copper-Containing Mesoporous Glass Nanoparticles as Antibacterial and Proangiogenic Agents for Chronic Wounds.

Authors:  Thomas E Paterson; Alessandra Bari; Anthony J Bullock; Robert Turner; Giorgia Montalbano; Sonia Fiorilli; Chiara Vitale-Brovarone; Sheila MacNeil; Joanna Shepherd
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31

8.  Injectable Thermosensitive Formulation Based on Polyurethane Hydrogel/Mesoporous Glasses for Sustained Co-Delivery of Functional Ions and Drugs.

Authors:  Monica Boffito; Carlotta Pontremoli; Sonia Fiorilli; Rossella Laurano; Gianluca Ciardelli; Chiara Vitale-Brovarone
Journal:  Pharmaceutics       Date:  2019-10-01       Impact factor: 6.321

Review 9.  Copper-based biomaterials for bone and cartilage tissue engineering.

Authors:  Yufeng Wang; Wei Zhang; Qingqiang Yao
Journal:  J Orthop Translat       Date:  2021-05-19       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.